PillRight U.S. Preview Terms
Last reviewed: June 12, 2026
Preview-only status
The U.S. preview is not a translated version of the Korea medication checker. It is a separate source-review workspace for future U.S. drug safety pages and remains noindex until release checks pass.
Medical information boundary
- PillRight does not provide diagnosis, treatment, prescribing, or individualized medical advice.
- Do not start, stop, combine, or change medication based only on the U.S. preview.
- Use a licensed clinician, pharmacist, emergency service, or poison control center when appropriate.
- Official labels and approval records can change after a preview page is reviewed.
Source-review status
U.S. preview pages may show source mapping, candidate decisions, and publication blockers. These review states are not claims that a drug page is complete, publishable, or appropriate for a specific person.
Advertising and monetization
The U.S. preview should remain ad-free and affiliate-free during launch preparation. Monetization should not be added until content review, policy pages, and invalid-traffic monitoring are ready.